1. Circulating Glioma Biomarkers: Agents of Detection

    High-grade gliomas represent one of the most aggressive and treatment-resistant types of human brain cancer, with a median survival rate of only 14.6 months for patients with grade IV glioma (glioblastoma) [1,2].
  2. Tracking Cancer Immunotherapy: Dendritic Cell-Derived Exosomes

    Dendritic cells (DCs) are essential in order to combat invading viruses and trigger antiviral responses. New immunotherapy techniques to fight cancer are based on a DC’s ability to capture foreign antigens and innately present them to specific cytotoxic T cells.

2 Item(s)

To Top